CC Quote, Financials, Valuation and Earnings

Ashland, Inc. has a net margin of -4.66% compared to The Chemours Co.'s net margin of -3.63%. The Chemours Co.'s return on equity of -99.38% beat Ashland, Inc.'s return on equity of -30.96%.

The Chemours Co. has a consensus price target of $19.33, signalling downside risk potential of -10.29%. On the other hand Ashland, Inc. has an analysts' consensus of $68.00 which suggests that it could grow by 25.02%. Given that Ashland, Inc. has higher upside potential than The Chemours Co., analysts believe Ashland, Inc. is more attractive than The Chemours Co..

The Chemours Co. has a beta of 1.411, which suggesting that the stock is 41.119% more volatile than S&P 500. In comparison Ashland, Inc. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.255%.

The Chemours Co. has a quarterly dividend of $0.09 per share corresponding to a yield of 1.62%. Ashland, Inc. offers a yield of 3.11% to investors and pays a quarterly dividend of $0.42 per share. The Chemours Co. pays 174.61% of its earnings as a dividend. Ashland, Inc. pays out 46.75% of its earnings as a dividend. Ashland, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but The Chemours Co.'s is not.

The Chemours Co. quarterly revenues are $1.3B, which are larger than Ashland, Inc. quarterly revenues of $386M. The Chemours Co.'s net income of -$62M is lower than Ashland, Inc.'s net income of -$14M. Notably, The Chemours Co.'s price-to-earnings ratio is 66.47x while Ashland, Inc.'s PE ratio is 21.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours Co. is 0.56x versus 1.37x for Ashland, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

LSB Industries, Inc. has a net margin of -4.66% compared to The Chemours Co.'s net margin of 9.77%. The Chemours Co.'s return on equity of -99.38% beat LSB Industries, Inc.'s return on equity of 4.92%.

The Chemours Co. has a consensus price target of $19.33, signalling downside risk potential of -10.29%. On the other hand LSB Industries, Inc. has an analysts' consensus of $14.90 which suggests that it could fall by -0.07%. Given that The Chemours Co. has more downside risk than LSB Industries, Inc., analysts believe LSB Industries, Inc. is more attractive than The Chemours Co..

The Chemours Co. has a beta of 1.411, which suggesting that the stock is 41.119% more volatile than S&P 500. In comparison LSB Industries, Inc. has a beta of 0.477, suggesting its less volatile than the S&P 500 by 52.275%.

The Chemours Co. has a quarterly dividend of $0.09 per share corresponding to a yield of 1.62%. LSB Industries, Inc. offers a yield of 0.1% to investors and pays a quarterly dividend of $0.00 per share. The Chemours Co. pays 174.61% of its earnings as a dividend. LSB Industries, Inc. pays out -- of its earnings as a dividend.

The Chemours Co. quarterly revenues are $1.3B, which are larger than LSB Industries, Inc. quarterly revenues of $165M. The Chemours Co.'s net income of -$62M is lower than LSB Industries, Inc.'s net income of $16.1M. Notably, The Chemours Co.'s price-to-earnings ratio is 66.47x while LSB Industries, Inc.'s PE ratio is 43.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours Co. is 0.56x versus 1.74x for LSB Industries, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Ingevity Corp. has a net margin of -4.66% compared to The Chemours Co.'s net margin of -30.89%. The Chemours Co.'s return on equity of -99.38% beat Ingevity Corp.'s return on equity of -114.16%.

The Chemours Co. has a consensus price target of $19.33, signalling downside risk potential of -10.29%. On the other hand Ingevity Corp. has an analysts' consensus of $79.25 which suggests that it could grow by 11.48%. Given that Ingevity Corp. has higher upside potential than The Chemours Co., analysts believe Ingevity Corp. is more attractive than The Chemours Co..

The Chemours Co. has a beta of 1.411, which suggesting that the stock is 41.119% more volatile than S&P 500. In comparison Ingevity Corp. has a beta of 1.270, suggesting its more volatile than the S&P 500 by 27.038%.

The Chemours Co. has a quarterly dividend of $0.09 per share corresponding to a yield of 1.62%. Ingevity Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Chemours Co. pays 174.61% of its earnings as a dividend. Ingevity Corp. pays out -- of its earnings as a dividend.

The Chemours Co. quarterly revenues are $1.3B, which are larger than Ingevity Corp. quarterly revenues of $255.1M. The Chemours Co.'s net income of -$62M is higher than Ingevity Corp.'s net income of -$78.8M. Notably, The Chemours Co.'s price-to-earnings ratio is 66.47x while Ingevity Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours Co. is 0.56x versus 2.06x for Ingevity Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Rayonier Advanced Materials, Inc. has a net margin of -4.66% compared to The Chemours Co.'s net margin of -5.04%. The Chemours Co.'s return on equity of -99.38% beat Rayonier Advanced Materials, Inc.'s return on equity of -86.08%.

The Chemours Co. has a consensus price target of $19.33, signalling downside risk potential of -10.29%. On the other hand Rayonier Advanced Materials, Inc. has an analysts' consensus of $14.50 which suggests that it could grow by 36.54%. Given that Rayonier Advanced Materials, Inc. has higher upside potential than The Chemours Co., analysts believe Rayonier Advanced Materials, Inc. is more attractive than The Chemours Co..

The Chemours Co. has a beta of 1.411, which suggesting that the stock is 41.119% more volatile than S&P 500. In comparison Rayonier Advanced Materials, Inc. has a beta of 2.030, suggesting its more volatile than the S&P 500 by 103.046%.

The Chemours Co. has a quarterly dividend of $0.09 per share corresponding to a yield of 1.62%. Rayonier Advanced Materials, Inc. offers a yield of 2.76% to investors and pays a quarterly dividend of $0.00 per share. The Chemours Co. pays 174.61% of its earnings as a dividend. Rayonier Advanced Materials, Inc. pays out -- of its earnings as a dividend.

The Chemours Co. quarterly revenues are $1.3B, which are larger than Rayonier Advanced Materials, Inc. quarterly revenues of $417M. The Chemours Co.'s net income of -$62M is lower than Rayonier Advanced Materials, Inc.'s net income of -$21M. Notably, The Chemours Co.'s price-to-earnings ratio is 66.47x while Rayonier Advanced Materials, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Chemours Co. is 0.56x versus 0.46x for Rayonier Advanced Materials, Inc.. Usually stocks with elevated PS ratios are considered overvalued.